Reuters logo
BRIEF-Recro Pharma acquires Novel Neuromuscular blocking agents
July 5, 2017 / 12:20 PM / in 5 months

BRIEF-Recro Pharma acquires Novel Neuromuscular blocking agents

July 5 (Reuters) - Recro Pharma Inc

* Recro Pharma acquires Novel Neuromuscular blocking agents

* Says ‍under terms of agreement, Recro Pharma will pay Cornell a six figure initial up-front fee​

* Recro Pharma Inc - under terms of agreement, Recro Pharma will pay Cornell a six figure initial up-front fee

* Recro Pharma - ‍cornell entitled to receive additional milestone payments in millions per each acquired candidate upon achievement of certain U.S., EU regulatory approval Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below